Febuxostat Lowers Uric Acid Lower Uric Acid Febuxostat is hailed as the new millennium’s gout wonder drug. The first new gout drug in 40 years. But is it any good? This new treatment for lowering uric acid has been trialled extensively throughout the world. The last two years have seen a raft of trial results published, and gradual adoption by health authorities in different countries. It has been marketed under the brand name Adenuric, or Adenuric TMX-67, and most recently, in the US as Uloric. FDA acceptance marks a significant milestone in the acceptance of this new gout treatment. It’s manufacturers gained the confidence of the FDA in November 2008, when they recommended approval based on extensive febuxostat research. From February 2009 it will be marketed in the US as Uloric. The most significant aspect of Uloric is it’s use when allopurinol cannot be tolerated. Lowering uric acid is crucial to gout sufferers. Anything that helps gout patients to lower uric acid is a very very good thing. Just as with allopurinol, you are likely to need pain relief until all uric acid crystals (urate) in your body have dissolved. Once the treatment has rid you of urate build-up, you can continue to take it daily, and live a gout free life If you use Adenuric, or Uloric, or have opinions about using it, please discuss it in the febuxostat forum. Febuxostat Page Created: 17th February 2009 - Last Reviewed: 17th February 2009
|
